Clinical Trials in Nashville

Showing 7401-7420 of 20,298 trials

A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old

NCT04414397

The objectives of this study are to evaluate the safety and effectiveness of Juvederm® Voluma® XC injectable gel in adult participants seeking correction of temple hollowing

Temple Hollowing

Allergan205 participantsStarted May 2020

Los Angeles, California, United States • Newport Beach, California, United States • Boca Raton, Florida, United States +12 more locations

COMPLETEDPhase 3< 1 mile

Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab

NCT03875729

The purpose of this study is to determine whether teplizumab slows the loss of β cells and preserves β cell function in children and adolescent 8-17 years old who have been diagnosed with T1D in the previous 6 weeks.. Subjects will receive two courses of either teplizumab or placebo treatment 6 months apart.

Type 1 Diabetes Mellitus

Provention Bio, Inc.328 participantsStarted Apr 2019

San Diego, California, United States • San Francisco, California, United States • Walnut Creek, California, United States +59 more locations

A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old

Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab

Find Trials by Condition in Nashville

The Afolabi Stroke Registry for Children and Young Adults With SCD in Northern Nigeria

Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Devices Using the CardioMEMS™

The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke

Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment

Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease

Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility

Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus

Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advanced Solid Tumors

Post Market Study of Parietene™ DS Composite Mesh in Ventral Hernia Repair

Mogamulizumab Q4week Dosing in Participants With R/R CTCL

A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary

Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants

Management of Chronic Low Back Pain in Older Adults Using Auricular Point Acupressure

Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS

KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid Tumors

Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell Lymphoma

A Study Of PF-04449913 In Select Hematologic Malignancies